David O. Watson files Rule 144 for 2,475 shares

David O. Watson filed a Form 144 notice to sell 2,475 shares of common stock through Fidelity Brokerage Services LLC on or about January 20, 2026 on NASDAQ.

Rhea-AI Filing Summary

David O. Watson filed a Form 144 notice to sell 2,475 shares of common stock through Fidelity Brokerage Services LLC on or about January 20, 2026 on NASDAQ. The shares to be sold have an aggregate market value of $48,987.43, compared with 126,525,218 shares outstanding. These securities were acquired as restricted stock that vested on January 16, 2026 as compensation from the issuer. In the prior three months, Watson sold 5,000, 5,000, and 5,780 shares of common stock for gross proceeds of $100,300.00, $122,450.00, and $128,242.01, respectively.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does this Form 144 filing indicate for APLS?

It shows that David O. Watson has given notice of his intent to sell 2,475 shares of common stock under Rule 144 on or about January 20, 2026 on NASDAQ.

How many APLS shares is David O. Watson planning to sell under this Form 144?

He plans to sell 2,475 shares of common stock, with an indicated aggregate market value of $48,987.43.

How and when did David O. Watson acquire the APLS shares being sold?

The 2,475 shares were acquired as restricted stock vesting from the issuer on January 16, 2026, with the nature of payment listed as compensation.

What APLS share sales has David O. Watson made in the past three months?

Over the past three months, he sold 5,000 shares on November 17, 2025 for $100,300.00, 5,000 shares on December 16, 2025 for $122,450.00, and 5,780 shares on January 13, 2026 for $128,242.01.

Which broker and exchange are involved in this planned APLS share sale?

The planned sale of 2,475 common shares is through Fidelity Brokerage Services LLC, and the securities are listed on NASDAQ.

How many APLS shares are reported outstanding in this Form 144?

The notice reports 126,525,218 shares of common stock outstanding for the issuer.

What representation does the seller make in this Form 144 for APLS?

The seller represents that he does not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/20/2026 - 03:41 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001657719
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Apellis Pharmaceuticals, Inc.
SEC File Number	001-38276
Address of Issuer	100 FIFTH AVENUE WALTHAM MASSACHUSETTS 02451
Phone	617-977-5700
Name of Person for Whose Account the Securities are To Be Sold	Watson David O.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2475	48987.43	126525218	01/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/16/2026	Restricted Stock Vesting	Issuer			2475	01/16/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David O. Watson 100 Fifth Avenue Waltham MA 02451	Common	11/17/2025	5000	100300.00
David O. Watson 100 Fifth Avenue Waltham MA 02451	Common	12/16/2025	5000	122450.00
David O. Watson 100 Fifth Avenue Waltham MA 02451	Common	01/13/2026	5780	128242.01

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	01/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joshua Schmitt, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for David O. Watson.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)